查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475016

全球药品包装材料市场评估：依包装类型、依原料、依药物输送、依最终用户、依地区、机会、预测（2017-2031）

Pharma Packaging Materials Market Assessment, By Packaging Type, By Raw Material, By Drug Delivery, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 233 Pages | 商品交期: 3-5个工作天内

价格

全球医药包装材料市场规模预计将从 2023 年的 1,216.1 亿美元增至 2031 年的 2,616.3 亿美元，预计 2024-2031 年期间复合年增长率为 10.1%。 市场的成长可归因于製药业的扩张和医疗产业支出的增加。

药品和药品需求的不断增长是加强药品包装材料需求的主要因素。 例如，根据美国疾病管制与预防中心在 2023 年 11 月审查的估计，大约 71.9% 的就诊涉及药物治疗，大约开出了 10 亿种药物。 常用的处方药物包括维生素、止痛药和降血脂药。 这些不断增长的需求正在推动对药品包装材料的需求。 FDA等各种监管机构对药品包装的收紧加强了对药品包装材料的投资，从而对市场扩张产生了积极影响。

日益增长的环境问题已将重点放在开发可持续药品包装材料上，以支持市场扩张。 各製造商扩大开发技术上可回收的药品包装材料也进一步推动了市场的成长。

例如，难以回收废弃物回收和再利用领域的全球领导者 TerraCycle 已将Honeywell的 Aclar 阻隔薄膜泡罩认证为技术上可回收的 PETG 和 PVC 泡罩。 该薄膜是我们生命科学产品组合的一部分，透过提供防潮保护来帮助保护药物，以确保稳定性并保持药物功效。 这些成就催生了回收医药泡罩包装等多层材料的方法，支持了市场的扩张。

医疗和製药业的扩张推动市场成长

製药和医疗领域投资的增加，以及製造流程和技术创新的进步，正在为市场创造利润丰厚的成长机会。 例如，投资印度公司估计，到 2027 财年，印度医院部门的收入将达到 2,192 亿美元。 这一增长预计将增加对药品包装材料的需求并扩大市场。

医疗保健行业的成长可归因于大公司投资的增加、对医疗保健系统提供的各种福利的认识提高、收入水平的提高以及对医疗保健的重视。 这种增长增加了药品的使用以及对药品包装材料的需求。 各种疾病和病症的流行对药品和药品，特别是药品供应提出了进一步的需求，促使对药品包装材料的需求增加。 这些因素对市场成长做出了重大贡献。

专注于永续药品包装开发为市场提供利润丰厚的成长机会

世界各地的各种製药和医疗公司正在开发全面的永续包装计划，以减少碳足迹并减少整个包装供应链对塑胶的依赖。 由于环保意识不断增强，消费者对环保包装产品的需求不断增加，进一步鼓励製药公司采用永续包装解决方案，为消费者提供环保替代方案。 为了满足对永续包装解决方案日益增长的需求，各领先製药公司正在加大对合作伙伴的投资，以减少包装对环境造成的负面影响。 此类合作伙伴关係和举措正在市场上创造利润丰厚的成长机会。

此外，由于日益关注的环境问题，医疗器材和药品包装的主要供应商正在加大努力，确保开发由 100% 再生塑胶製成的药瓶。 例如，2024 年 1 月，领先的清洁技术公司 Loop Industries, Inc. 和国际医疗器材和药品包装供应商 Bormioli Pharma 将推出 100% 回收的、品质如新的 Loop PET 树脂。 这种高品质的替代药品包装正在为製药业的可持续包装制定新标准，并推动此类解决方案的开发投资，支持市场扩张。

本报告研究和分析了全球医药包装材料市场，提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章顾客回馈

  • 市场认知度与产品讯息
  • 品牌知名度与忠诚度
  • 购买决策时考虑的因素
  • 购买频率
  • 购买介质

第五章全球药包材市场展望（2017-2031）

  • 市场规模与预测
    • 金额
    • 数量
  • 依包装类型
    • 小学
    • 中学
    • 第三
  • 依原料分类
    • 塑料
    • 金属
    • 玻璃
    • 纸、纸板
    • 其他
  • 透过药物输送
    • 口腔医学
    • 外用药
    • 注射药品
    • 肺
    • 鼻腔
    • 眼科
    • 静脉注射用药
    • 透皮
    • 其他
  • 依最终用户
    • 药品製造
    • 零售药局
    • 合约包装
    • 设施药房
  • 依地区
    • 北美
    • 南美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 市占率：依公司划分（2023 年）

第六章全球药品包装材料市场展望：依地区（2017-2031）

  • 北美
    • 市场规模与预测
    • 依包装类型
    • 依原料分类
    • 透过药物输送
    • 依最终用户
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 南美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第七章供给面分析

  • 生产能力：依公司划分
  • 生产：依公司划分
  • 营运效率：依公司划分
  • 主要工厂地点（最多 25 个地点）

第 8 章市场地图（2023 年）

  • 依包装类型
  • 依原料分类
  • 透过药物输送
  • 依最终用户
  • 依地区

第九章宏观环境与产业结构

  • 需求与供给分析
  • 进出口分析
  • 供应链分析
  • PESTEL 分析
  • 波特五力分析

第 10 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题、限制因素）

第十一章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析（2023 年）
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家市场公司）
  • 专利分析（如果适用）

第十二章价格分析

第 13 章案例研究

第14章主要公司展望

  • Amcor plc
  • Berry Global Group, Inc.
  • Gerresheimer AG
  • Schott AG
  • AptarGroup Inc.
  • Catalent, Inc.
  • WestRock Company
  • Becton, Dickinson, and Company
  • Nipro Corporation
  • CCL Industries Inc.

第 15 章策略建议

第十六章关于我们公司，免责声明

Product Code: MX11283

Global pharma packaging materials market is projected to witness a CAGR of 10.1% during the forecast period 2024-2031, growing from USD 121.61 billion in 2023 to USD 261.63 billion in 2031F. The growth of the market can be attributed to the expansion of the pharmaceutical sector and the increase in expenditure in the healthcare sector.

The rising requirement for drugs and medication is a major factor bolstering the requirement for pharma packaging materials. For instance, according to the estimates of Center for Disease Control and Prevention reviewed in November 2023, approximately 71.9% of physician office visits involve drug therapy and around 1 billion drugs are prescribed. The frequently prescribed classes of therapeutics include vitamins, analgesics, and antihyperlipidemic agents. The increased requirement is thus bolstering the demand for pharma packaging materials. The growing strictness of different regulatory bodies, such as FDA, towards pharmaceutical packaging is bolstering investments in pharma packaging materials, which in turn is positively influencing the global pharma packaging materials market expansion.

The increasing emphasis on the development of sustainable pharmaceutical packaging materials owing to rising environmental concerns is supporting the market's expansion. The augmenting efforts of various manufacturing companies to develop pharmaceutical packaging materials with technical recyclability further boost the market growth.

For instance, TerraCycle, a global leader in collecting and repurposing hard to recycle waste recognized Honeywell's Aclar Barrier Film Blisters as technically recyclable for PETG and PVC-based blisters. The film is a part of their Life Sciences portfolio and aids in protecting the drugs by providing moisture barrier protection to preserve the efficacy of the medicines and ensure the stability of the drug. Such achievements are supporting the expansion of the market as they provide methodologies for recycling multi-layer materials such as pharmaceutical blister packaging.

Expansion of Healthcare and Pharmaceutical Sectors Boosts Global Pharma Packaging Materials Market Growth

The increasing investments in the pharmaceutical and healthcare sector, along with advancements in manufacturing processes and technological innovations, provide lucrative growth opportunities to the market. For instance, Invest India estimated that the hospital sector in India will reach USD 219.2 billion (INR 18,348.78 billion) in revenue by the financial year 2027. The growth is expected to bolster the requirement for pharmaceutical packaging materials, supporting the expansion of the market.

The growth of the healthcare sector can be attributed to the rising investments by leading companies, increasing awareness about various benefits offered by the healthcare systems, rising income levels, and growing emphasis on health management. Due to the growth, the utilization of pharmaceutical products is augmenting, bolstering the demand for pharma packaging materials. The rising prevalence of various diseases and disorders further boosts the requirement for drugs and medications, among other pharmaceutical supplies, resulting in an increased demand for pharma packaging materials. These factors are heavily contributing to the growth of the market.

Increasing Emphasis on Development of Sustainable Pharma Packaging Provides Lucrative Growth Opportunities to the Market

Various pharmaceutical and healthcare companies across the globe are developing comprehensive sustainability packaging programs to reduce their carbon footprint and decrease their reliance on plastic across the packaging supply chain. Increased consumer demand for environment-friendly packaging products, owing to rising environmental consciousness, is further encouraging pharmaceutical companies to adopt sustainable packaging solutions and provide eco-friendly alternatives to consumers. To meet the increase in demand for sustainable packaging solutions, various leading pharmaceutical companies have boosted their investments in collaborations to reduce the negative environmental impact caused by their packaging. Such collaborations and efforts are providing lucrative growth opportunities to the market.

Moreover, due to growing concerns about the environment, leading providers of medical devices and pharmaceutical packaging are boosting their efforts to ensure the development of pharmaceutical bottles with 100% recycled plastic. For instance, in January 2024, Loop Industries, Inc., a leading clean technology company and Bormioli Pharma, an international provider of medical devices and pharmaceutical packaging, launched pharma packaging bottles that were developed using 100% recycled virgin-quality Loop PET resin. Such high-quality pharma packaging alternatives are aiding in establishing new standards for sustainable packaging in the pharmaceutical sector and bolstering investments towards developing such solutions, thus supporting the expansion of the market.

Asia-Pacific Accounts for Significant Market Share

The growth of the Asia-Pacific market can be attributed to the strong presence of key market players, the rapid expansion of the pharmaceutical sector, and increasing investments in the healthcare sector. The demand for pharma packaging materials is rising due to the increased requirement for different pharmaceutical products owing to rapid population growth. The increase in research and development activities in the pharmaceutical sector, coupled with the production of novel medications, is further bolstering the demand for pharma packaging materials in Asia-Pacific.

Additionally, the rapid expansion of the pharmaceutical sector supports market growth. For instance, Invest India estimates that the pharmaceutical market in the country will reach USD 130 billion by 2030. Moreover, India exports pharmaceutical products to over 200 countries, supplying approx. 25% of all medicines in the United Kingdom, around 40% of generic demand in the United States, and over 50% of Africa's requirement for generics. Additionally, 70% of WHOs vaccines are sourced from India. Thus, due to the growth in the requirement and export of different pharmaceutical products, the demand for pharma packaging materials is rising, boosting the market's growth.

Technological Advancements in Primary Packaging Aid Market Expansion

The increasing integration of radiofrequency identification in various packaging, such as prefilled syringes coupled with increased efforts towards development of counterfeit prevention mechanisms are supporting the growth of the market. For instance, the developments in printing techniques and 3D visualization are aiding in pushing the design boundaries of primary as well as secondary packaging, allowing companies to save time and money in development costs and material wastage. Such advancements will positively influence the growth of the market over the forecast period. Additionally, using primary packaging provides a compatible and safe barrier for medications. Due to it, the efforts to enhance the development of primary packaging are increasing, supporting the segment's expansion.

Pharmaceutical Manufacturing Will Boost Market Demand

The rising requirement for pharma packaging materials by the pharmaceutical manufacturing sector can be attributed to the increased demand for medications due to the expansion of the geriatric population and the growing prevalence of various diseases and disorders. According to WHO, by 2030, one in six individuals across the globe will be aged 60 or above, and by 2050, approximately 2.1 billion individuals will be 60 or older. The expansion of the geriatric population will bolster the demand for various pharmaceutical products as they are more prone to illnesses, propelling the requirement for pharma packaging materials and augmenting the growth of the market.

Additionally, the rapid expansion of pharmaceutical industry in various regions is further aiding the expansion of the market. For instance, the European Federation of Pharmaceutical Industries and Associations estimates that North America accounted for 49.1% of global pharmaceutical sales, while Europe accounted for 23.4%. Due to the rise in sales of pharmaceuticals, the demand for pharma packaging materials is rising, positively influencing the growth of the market.

Future Market Scenario (2024 - 2031F)

According to global pharma packaging materials market analysis, the market will witness significant growth over the forecast period owing to growing potential of automation, artificial intelligence, and blockchain technology for optimizing the traceability of finished products and streamlining the pharmaceutical packaging process. The requirement for intelligent packaging processes along with multiple packaging formats will witness an increase.

Furthermore, the utilization of pre-filled syringes and single-use vials that have the ability to accommodate a wider range of formulations and dosages and smaller volumes of medication will rise. The direct delivery of personalized treatment solutions to the patients will boost the demand for packaging materials that will protect the medications against various environmental factors. Thus, boosting the growth of the market and supporting the market expansion.

Additionally, due to the increasing emphasis on sustainability and burgeoning environmental crisis, various leading market players are actively investing towards the development of eco-friendly and biodegradable pharma packaging materials. Thus, providing lucrative growth opportunities to the market.

Key Players Landscape and Outlook

The increasing development of sustainable pharmaceutical packaging solutions will boost the growth of the market. For instance, high-barrier PVDC coating provided by Solvay provides an ultra-high water vapor barrier. It enables thin thermoforming films, aiding the pharma packaging material manufacturers to reduce their carbon footprint. The Diofan Ultra736's robust barrier properties allow for reduced coating thickness, with no negative effects on the performance of the package. The product contains no fluorine, allowing it to meet the regulatory requirements for direct pharmaceutical contact. Such product developments will aid the pharma packaging materials manufacturers in reducing their carbon footprint, positively influencing the growth of the market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Pharma Packaging Materials Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Packaging Type
    • 5.2.1.Primary
      • 5.2.1.1.Plastic Bottles
      • 5.2.1.2.Caps and Closures
      • 5.2.1.3.Parenteral Containers
        • 5.2.1.3.1.Syringes
        • 5.2.1.3.2.Vials and Ampoules
        • 5.2.1.3.3.Others
      • 5.2.1.4.Blister Packs
      • 5.2.1.5.Prefillable Inhalers
      • 5.2.1.6.Pouches
      • 5.2.1.7.Medication Tubes
      • 5.2.1.8.Others
    • 5.2.2.Secondary
      • 5.2.2.1.Prescription Containers
      • 5.2.2.2.Pharmaceutical Packaging Accessories
    • 5.2.3.Tertiary
  • 5.3.By Raw Material
    • 5.3.1.Plastic
    • 5.3.2.Metal
    • 5.3.3.Glass
    • 5.3.4.Paper and Paperboards
    • 5.3.5.Others
  • 5.4.By Drug Delivery
    • 5.4.1.Oral Drugs
    • 5.4.2.Topicals
    • 5.4.3.Injectables
    • 5.4.4.Pulmonary
    • 5.4.5.Nasal
    • 5.4.6.Ocular/ Ophthalmic
    • 5.4.7.IV Drugs
    • 5.4.8.Transdermal
    • 5.4.9.Others
  • 5.5.By End-user
    • 5.5.1.Pharmaceutical Manufacturing
    • 5.5.2.Retail Pharmacy
    • 5.5.3.Contract Packaging
    • 5.5.4.Institutional Pharmacy
  • 5.6.By Region
    • 5.6.1.North America
    • 5.6.2.South America
    • 5.6.3.Europe
    • 5.6.4.Asia-Pacific
    • 5.6.5.Middle East & Africa
  • 5.7.By Company Market Share (%), 2023

6.Global Pharma Packaging Materials Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Packaging Type
      • 6.1.2.1.Primary
        • 6.1.2.1.1.Plastic Bottles
        • 6.1.2.1.2.Caps and Closures
        • 6.1.2.1.3.Parenteral Containers
          • 6.1.2.1.3.1.Syringes
          • 6.1.2.1.3.2.Vials and Ampoules
          • 6.1.2.1.3.3.Others
        • 6.1.2.1.4.Blister Packs
        • 6.1.2.1.5.Prefillable Inhalers
        • 6.1.2.1.6.Pouches
        • 6.1.2.1.7.Medication Tubes
        • 6.1.2.1.8.Others
      • 6.1.2.2.Secondary
        • 6.1.2.2.1.Prescription Containers
        • 6.1.2.2.2.Pharmaceutical Packaging Accessories
      • 6.1.2.3.Tertiary
    • 6.1.3.By Raw Material
      • 6.1.3.1.Plastic
      • 6.1.3.2.Metal
      • 6.1.3.3.Glass
      • 6.1.3.4.Paper and Paperboards
      • 6.1.3.5.Others
    • 6.1.4.By Drug Delivery
      • 6.1.4.1.Oral Drugs
      • 6.1.4.2.Topicals
      • 6.1.4.3.Injectables
      • 6.1.4.4.Pulmonary
      • 6.1.4.5.Nasal
      • 6.1.4.6.Ocular/ Ophthalmic
      • 6.1.4.7.IV Drugs
      • 6.1.4.8.Transdermal
      • 6.1.4.9.Others
    • 6.1.5.By End-user
      • 6.1.5.1.Pharmaceutical Manufacturing
      • 6.1.5.2.Retail Pharmacy
      • 6.1.5.3.Contract Packaging
      • 6.1.5.4.Institutional Pharmacy
    • 6.1.6.United States*
      • 6.1.6.1.Market Size & Forecast
        • 6.1.6.1.1.By Value
        • 6.1.6.1.2.By Volume
      • 6.1.6.2.By Packaging Type
        • 6.1.6.2.1.Primary
          • 6.1.6.2.1.1.Plastic Bottles
          • 6.1.6.2.1.2.Caps and Closures
          • 6.1.6.2.1.3.Parenteral Containers
          • 6.1.6.2.1.3.1.Syringes
          • 6.1.6.2.1.3.2.Vials and Ampoules
          • 6.1.6.2.1.3.3.Others
          • 6.1.6.2.1.4.Blister Packs
          • 6.1.6.2.1.5.Prefillable Inhalers
          • 6.1.6.2.1.6.Pouches
          • 6.1.6.2.1.7.Medication Tubes
          • 6.1.6.2.1.8.Others
        • 6.1.6.2.2.Secondary
          • 6.1.6.2.2.1.Prescription Containers
          • 6.1.6.2.2.2.Pharmaceutical Packaging Accessories
        • 6.1.6.2.3.Tertiary
      • 6.1.6.3.By Raw Material
        • 6.1.6.3.1.Plastic
        • 6.1.6.3.2.Metal
        • 6.1.6.3.3.Glass
        • 6.1.6.3.4.Paper and Paperboards
        • 6.1.6.3.5.Others
      • 6.1.6.4.By Drug Delivery
        • 6.1.6.4.1.Oral Drugs
        • 6.1.6.4.2.Topicals
        • 6.1.6.4.3.Injectables
        • 6.1.6.4.4.Pulmonary
        • 6.1.6.4.5.Nasal
        • 6.1.6.4.6.Ocular/ Ophthalmic
        • 6.1.6.4.7.IV Drugs
        • 6.1.6.4.8.Transdermal
        • 6.1.6.4.9.Others
      • 6.1.6.5.By End-user
        • 6.1.6.5.1.Pharmaceutical Manufacturing
        • 6.1.6.5.2.Retail Pharmacy
        • 6.1.6.5.3.Contract Packaging
        • 6.1.6.5.4.Institutional Pharmacy
    • 6.1.7.Canada
    • 6.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Packaging Type
  • 8.2.By Raw Material
  • 8.3.By Drug Delivery
  • 8.4.By End-user
  • 8.5.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.Amcor plc
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Berry Global Group, Inc.
  • 14.3.Gerresheimer AG
  • 14.4.Schott AG
  • 14.5.AptarGroup Inc.
  • 14.6.Catalent, Inc.
  • 14.7.WestRock Company
  • 14.8.Becton, Dickinson, and Company
  • 14.9.Nipro Corporation
  • 14.10.CCL Industries Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 3.Global Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 4.Global Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 5.Global Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 6.Global Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Pharma Packaging Materials Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 10.North America Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 11.North America Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 12.North America Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 13.North America Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 17.United States Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 18.United States Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 19.United States Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 20.United States Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 23.Canada Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 24.Canada Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 25.Canada Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 26.Canada Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 29.Mexico Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 30.Mexico Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 31.Mexico Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 32.Mexico Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 35.Europe Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 36.Europe Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 37.Europe Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 38.Europe Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 42.Germany Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 43.Germany Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 44.Germany Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 45.Germany Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 48.France Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 49.France Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 50.France Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 51.France Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 54.Italy Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 55.Italy Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 56.Italy Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 57.Italy Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 60.United Kingdom Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 61.United Kingdom Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 62.United Kingdom Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 63.United Kingdom Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 66.Russia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 67.Russia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 68.Russia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 69.Russia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 72.Netherlands Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 73.Netherlands Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 74.Netherlands Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 75.Netherlands Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 78.Spain Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 79.Spain Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 80.Spain Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 81.Spain Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 84.Turkey Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 85.Turkey Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 86.Turkey Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 87.Turkey Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 90.Poland Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 91.Poland Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 92.Poland Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 93.Poland Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 96.South America Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 97.South America Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 98.South America Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 99.South America Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 103.Brazil Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 104.Brazil Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 105.Brazil Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 106.Brazil Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 109.Argentina Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 110.Argentina Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 111.Argentina Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 112.Argentina Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 115.Asia-Pacific Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 116.Asia-Pacific Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 117.Asia-Pacific Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 118.Asia-Pacific Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 120.India Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 122.India Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 123.India Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 124.India Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 125.India Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 128.China Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 129.China Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 130.China Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 131.China Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 134.Japan Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 135.Japan Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 136.Japan Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 137.Japan Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 140.Australia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 141.Australia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 142.Australia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 143.Australia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 146.Vietnam Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 147.Vietnam Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 148.Vietnam Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 149.Vietnam Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 152.South Korea Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 153.South Korea Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 154.South Korea Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 155.South Korea Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 158.Indonesia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 159.Indonesia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 160.Indonesia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 161.Indonesia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 164.Philippines Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 165.Philippines Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 166.Philippines Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 167.Philippines Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 170.Middle East & Africa Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 171.Middle East & Africa Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 172.Middle East & Africa Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 173.Middle East & Africa Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 177.Saudi Arabia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 178.Saudi Arabia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 179.Saudi Arabia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 180.Saudi Arabia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 183.UAE Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 184.UAE Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 185.UAE Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 186.UAE Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
  • Figure 189.South Africa Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
  • Figure 190.South Africa Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
  • Figure 191.South Africa Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
  • Figure 192.South Africa Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Packaging Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Raw Material Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Drug Delivery Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023